Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE). view more (2009-06-12)
